XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2024
Operating activities:          
Net loss $ (3,165) $ (2,186) $ (6,257)   $ (4,514)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:          
Income from discontinued operations, net of taxes 0 (167) 0   (358)
Loss on disposal of discontinued operations, net of taxes 0 0 0   404
Equity in net loss of limited liability investments     0   162
Depreciation and amortization expense     3,697   3,244
Stock-based compensation expense     761   585
Net realized gains (128) (277) (57)   (401)
Net loss on change in fair value of equity investments 0 0 0   3
Gain on change in fair value of limited liability investment, at fair value (177) (86) (178)   (78)
Impairment of Intangible Assets (Excluding Goodwill) 135 690 219   1,201
(Gain) loss on change in fair value of debt     (19)   129
Loss on change in fair value of derivatives     0   49
Loss on change in fair value of contingent consideration     0   270
Deferred income taxes     (571)   (108)
Amortization of fixed maturities premiums and discounts     (28)   (10)
Loss on extinguishment of debt 0 160 115   160
Changes in operating assets and liabilities:          
Service fee receivable, net, adjusted for assets acquired     (1,379)   214
Other receivables, net, adjusted for assets acquired     412   302
Deferred contract costs     (681)   (259)
Other assets, adjusted for assets acquired     (238)   (364)
Deferred service fees     3,322   874
Other, net, adjusted for liabilities acquired     (579)   (999)
Cash (used in) provided by operating activities - continuing operations     (1,461)   506
Cash provided by operating activities - discontinued operations     0   300
Net cash (used in) provided by operating activities     (1,461)   806
Investing activities:          
Proceeds from sales and maturities of fixed maturities     5,687   3,652
Proceeds from sales of equity investments     0   77
Purchases of fixed maturities     (5,688)   (3,439)
Net proceeds from limited liability investment, at fair value     95   1,052
Net proceeds from investments in private companies     107   16
Net (purchases of) proceeds from other investments and short-term investments     (4)   2
Acquisition of businesses, net of cash acquired     (13,631)   7
Net purchases of property and equipment, adjusted for assets acquired     (242)   (437)
Cash (used in) provided by investing activities - continuing operations     (13,676)   930
Cash used in investing activities - discontinued operations     0   0
Net cash (used in) provided by investing activities     (13,676)   930
Financing activities:          
Proceeds from issuance of common stock, net     15,602   0
Proceeds from issuance of preferred stock     8,000   0
Cash paid for repurchase of common stock     (345)   (954)
Distributions to noncontrolling interest holders     0   (678)
Payment of preferred stock dividends (200)   (389)   0
Payment of contingent consideration from acquisition     (420)   0
Taxes paid related to net share settlements of restricted stock awards     0   (1,844)
Principal proceeds from bank loans, net of debt issuance costs of $38 in 2025 and $123 in 2024     9,410   19,077
Principal payments on bank loans     (10,346)   (16,579)
Principal payments on note payable     (54)   0
Cash provided by (used in) financing activities - continuing operations     21,458   (978)
Cash used in financing activities - discontinued operations     0   (312)
Net cash provided by (used in) financing activities     21,458   (1,290)
Net increase in cash and cash equivalents and restricted cash from continuing operations     6,321   458
Cash and cash equivalents and restricted cash at beginning of period     13,136   18,110
Less: cash and cash equivalents and restricted cash of discontinued operations 0 612 0   612
Cash and cash equivalents and restricted cash of continuing operations at beginning of period     13,136 $ 17,956 17,498
Cash and cash equivalents and restricted cash of continuing operations at end of period 19,457 17,956 19,457 13,136 17,956
Reconciliation of cash and cash equivalents and restricted cash to the consolidated balance sheets:          
Cash and cash equivalents 12,079 9,594 12,079 5,493 9,594
Restricted cash 7,378 8,362 7,378 7,643 8,362
Cash and cash equivalents and restricted cash per statements of cash flows $ 19,457 $ 17,956 $ 19,457 $ 13,136 $ 17,956